nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Furosemide—dilated cardiomyopathy	0.65	1	CbGbCtD
Gadobenate Dimeglumine—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00944	0.027	CcSEcCtD
Gadobenate Dimeglumine—Atrioventricular block complete—Lisinopril—dilated cardiomyopathy	0.00845	0.0241	CcSEcCtD
Gadobenate Dimeglumine—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0071	0.0203	CcSEcCtD
Gadobenate Dimeglumine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00664	0.019	CcSEcCtD
Gadobenate Dimeglumine—Blister—Furosemide—dilated cardiomyopathy	0.00546	0.0156	CcSEcCtD
Gadobenate Dimeglumine—Glycosuria—Furosemide—dilated cardiomyopathy	0.00486	0.0139	CcSEcCtD
Gadobenate Dimeglumine—Injection site pain—Furosemide—dilated cardiomyopathy	0.00482	0.0138	CcSEcCtD
Gadobenate Dimeglumine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.0046	0.0131	CcSEcCtD
Gadobenate Dimeglumine—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0043	0.0123	CcSEcCtD
Gadobenate Dimeglumine—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00413	0.0118	CcSEcCtD
Gadobenate Dimeglumine—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.0041	0.0117	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00398	0.0114	CcSEcCtD
Gadobenate Dimeglumine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00361	0.0103	CcSEcCtD
Gadobenate Dimeglumine—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00336	0.00959	CcSEcCtD
Gadobenate Dimeglumine—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00331	0.00946	CcSEcCtD
Gadobenate Dimeglumine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00327	0.00933	CcSEcCtD
Gadobenate Dimeglumine—Swelling—Furosemide—dilated cardiomyopathy	0.00324	0.00924	CcSEcCtD
Gadobenate Dimeglumine—Cough increased—Lisinopril—dilated cardiomyopathy	0.00322	0.00921	CcSEcCtD
Gadobenate Dimeglumine—Deafness—Furosemide—dilated cardiomyopathy	0.00319	0.00911	CcSEcCtD
Gadobenate Dimeglumine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00314	0.00897	CcSEcCtD
Gadobenate Dimeglumine—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.0031	0.00885	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00304	0.00868	CcSEcCtD
Gadobenate Dimeglumine—Thirst—Furosemide—dilated cardiomyopathy	0.003	0.00857	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00299	0.00853	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00295	0.00843	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00295	0.00842	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00293	0.00837	CcSEcCtD
Gadobenate Dimeglumine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.0029	0.00828	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00287	0.00819	CcSEcCtD
Gadobenate Dimeglumine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00287	0.00818	CcSEcCtD
Gadobenate Dimeglumine—Wheezing—Lisinopril—dilated cardiomyopathy	0.00287	0.00818	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Spironolactone—dilated cardiomyopathy	0.00285	0.00814	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00283	0.00808	CcSEcCtD
Gadobenate Dimeglumine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00279	0.00796	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00268	0.00764	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00266	0.00759	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00263	0.0075	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0026	0.00743	CcSEcCtD
Gadobenate Dimeglumine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00259	0.00739	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00258	0.00737	CcSEcCtD
Gadobenate Dimeglumine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00245	0.007	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00229	0.00655	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00228	0.00651	CcSEcCtD
Gadobenate Dimeglumine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00226	0.00646	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00223	0.00636	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00223	0.00636	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00221	0.00632	CcSEcCtD
Gadobenate Dimeglumine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.0022	0.00627	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Furosemide—dilated cardiomyopathy	0.00216	0.00618	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00215	0.00614	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00214	0.00612	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00213	0.00607	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Furosemide—dilated cardiomyopathy	0.00211	0.00602	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00207	0.00591	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00205	0.00585	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00204	0.00582	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00204	0.00582	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00201	0.00573	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00195	0.00557	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00194	0.00553	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00192	0.00547	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Furosemide—dilated cardiomyopathy	0.0019	0.00544	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0019	0.00543	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Lisinopril—dilated cardiomyopathy	0.00185	0.00529	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00185	0.00527	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00184	0.00526	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00183	0.00521	CcSEcCtD
Gadobenate Dimeglumine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00182	0.0052	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00179	0.00512	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00178	0.00509	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00178	0.00509	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00177	0.00504	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00176	0.00504	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Furosemide—dilated cardiomyopathy	0.00172	0.00491	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00172	0.00491	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00171	0.00487	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00168	0.00481	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00167	0.00477	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00165	0.00472	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00164	0.00468	CcSEcCtD
Gadobenate Dimeglumine—Rash—Spironolactone—dilated cardiomyopathy	0.00163	0.00464	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00163	0.00464	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00162	0.00463	CcSEcCtD
Gadobenate Dimeglumine—Headache—Spironolactone—dilated cardiomyopathy	0.00162	0.00461	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00161	0.00458	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Furosemide—dilated cardiomyopathy	0.00159	0.00454	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Lisinopril—dilated cardiomyopathy	0.00158	0.00452	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00157	0.0045	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00154	0.0044	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Spironolactone—dilated cardiomyopathy	0.00153	0.00438	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00151	0.00431	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00149	0.00424	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00146	0.00418	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00146	0.00417	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00145	0.00415	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00145	0.00415	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00143	0.00409	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Furosemide—dilated cardiomyopathy	0.00142	0.00404	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0014	0.00401	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00138	0.00395	CcSEcCtD
Gadobenate Dimeglumine—Shock—Furosemide—dilated cardiomyopathy	0.00138	0.00394	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00138	0.00393	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Lisinopril—dilated cardiomyopathy	0.00138	0.00393	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00136	0.00389	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00136	0.00387	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00134	0.00384	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00134	0.00381	CcSEcCtD
Gadobenate Dimeglumine—Chills—Lisinopril—dilated cardiomyopathy	0.00133	0.0038	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00132	0.00378	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Furosemide—dilated cardiomyopathy	0.00131	0.00374	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.0013	0.00371	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00129	0.00368	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Lisinopril—dilated cardiomyopathy	0.00129	0.00368	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00126	0.00361	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00126	0.0036	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Lisinopril—dilated cardiomyopathy	0.00125	0.00356	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Furosemide—dilated cardiomyopathy	0.00125	0.00356	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00124	0.00354	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00121	0.00346	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Furosemide—dilated cardiomyopathy	0.00121	0.00346	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Lisinopril—dilated cardiomyopathy	0.00121	0.00345	CcSEcCtD
Gadobenate Dimeglumine—Pain—Furosemide—dilated cardiomyopathy	0.0012	0.00343	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Furosemide—dilated cardiomyopathy	0.0012	0.00343	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.0012	0.00342	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00119	0.00341	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00118	0.00337	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Lisinopril—dilated cardiomyopathy	0.00116	0.00332	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Lisinopril—dilated cardiomyopathy	0.00116	0.0033	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00116	0.0033	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00116	0.0033	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00115	0.00328	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00114	0.00326	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00113	0.00324	CcSEcCtD
Gadobenate Dimeglumine—Cough—Lisinopril—dilated cardiomyopathy	0.00113	0.00321	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Furosemide—dilated cardiomyopathy	0.00112	0.00318	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00111	0.00317	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00111	0.00317	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Lisinopril—dilated cardiomyopathy	0.0011	0.00314	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.0011	0.00314	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Lisinopril—dilated cardiomyopathy	0.0011	0.00314	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00109	0.00313	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00109	0.00311	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00109	0.0031	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00107	0.00307	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00106	0.00303	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00105	0.00301	CcSEcCtD
Gadobenate Dimeglumine—Infection—Lisinopril—dilated cardiomyopathy	0.00105	0.00299	CcSEcCtD
Gadobenate Dimeglumine—Shock—Lisinopril—dilated cardiomyopathy	0.00104	0.00296	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00103	0.00295	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00103	0.00293	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00102	0.00292	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00102	0.00291	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Furosemide—dilated cardiomyopathy	0.00101	0.00288	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Furosemide—dilated cardiomyopathy	0.000993	0.00284	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000984	0.00281	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00096	0.00274	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000959	0.00274	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000946	0.0027	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000939	0.00268	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000936	0.00267	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Furosemide—dilated cardiomyopathy	0.000928	0.00265	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000927	0.00265	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000909	0.0026	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000908	0.00259	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Lisinopril—dilated cardiomyopathy	0.000901	0.00257	CcSEcCtD
Gadobenate Dimeglumine—Pain—Lisinopril—dilated cardiomyopathy	0.000901	0.00257	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Furosemide—dilated cardiomyopathy	0.000892	0.00255	CcSEcCtD
Gadobenate Dimeglumine—Rash—Furosemide—dilated cardiomyopathy	0.000885	0.00253	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000884	0.00252	CcSEcCtD
Gadobenate Dimeglumine—Headache—Furosemide—dilated cardiomyopathy	0.000879	0.00251	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000868	0.00248	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000861	0.00246	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000837	0.00239	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Furosemide—dilated cardiomyopathy	0.000834	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000833	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000833	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000776	0.00222	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000756	0.00216	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000745	0.00213	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000721	0.00206	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000696	0.00199	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00067	0.00191	CcSEcCtD
Gadobenate Dimeglumine—Rash—Lisinopril—dilated cardiomyopathy	0.000664	0.0019	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000663	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Headache—Lisinopril—dilated cardiomyopathy	0.00066	0.00188	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Lisinopril—dilated cardiomyopathy	0.000626	0.00179	CcSEcCtD
